Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis

IMPORTANCE: Epilepsy is one of the most common neurologic disorders globally. Cannabidiol (CBD) has been approved for the treatment of epilepsy, but its use has been associated with several different adverse events (AEs). OBJECTIVE: To investigate the frequency and risk of AEs developing in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazlollahi, Asra, Zahmatyar, Mahdi, ZareDini, Mahta, Golabi, Behnam, Nejadghaderi, Seyed Aria, Sullman, Mark J. M., Gharagozli, Koroush, Kolahi, Ali-Asghar, Safiri, Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119734/
https://www.ncbi.nlm.nih.gov/pubmed/37079302
http://dx.doi.org/10.1001/jamanetworkopen.2023.9126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119734/
https://www.ncbi.nlm.nih.gov/pubmed/37079302
http://dx.doi.org/10.1001/jamanetworkopen.2023.9126

Ejemplares similares